Cafepharma Today

October 24 2024 - Weight-loss drugs didn't curb health costs within two years
Weight-loss drugs didn't curb health costs within two years
GSK answers Pfizer's RSV approval with data targeting matching nod in younger adults
Why pharma megamergers may become a relic of the past
Lundbeck planning for four novel drugs in phase 3 in 2026
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Crestor Cut Heart Risk in People With Low Cholesterol
Bloomberg
Monday, November 10, 2008 - 8:21am
tags:
Merck’s Heart Remains Steadfast in Hunt for Cardiovascular Drugs
WSJ Online
Monday, November 10, 2008 - 8:20am
tags:
Study Results Could Broaden Cholesterol Drug Market
Wall Street Journal
Sunday, November 9, 2008 - 10:07am
tags:
Wuxi, Pfizer Strengthen Relationship in New Deal
Seeking Alpha
Sunday, November 9, 2008 - 10:06am
tags:
Amgen: Remember Its Biotech Bloodlines?
Seeking Alpha
Sunday, November 9, 2008 - 10:05am
tags:
Roche sticks by $43.7 billion Genentech bid: report
Yahoo/Reuters
Sunday, November 9, 2008 - 10:00am
tags:
Charles River Blames Slowdown on Biopharmas' Need to Conserve Cash
Seeking Alpha
Sunday, November 9, 2008 - 9:59am
tags:
Study: Cholesterol drugs could help those with healthy levels
CNN
Sunday, November 9, 2008 - 9:57am
tags:
CRESTOR Demonstrates Dramatic CV Risk Reduction in a Large Statin Outcomes Study
PR NewsWire
Sunday, November 9, 2008 - 9:56am
tags:
Affymax Announces New Data Presented on the Long-Term Safety and Effectiveness of Hematide(TM) to Treat Anemia in Chronic Renal Failure Patients with Monthly Dosing
PR - Indside
Sunday, November 9, 2008 - 9:55am
tags:
Biovail Declares Quarterly Dividend
PR - Inside
Sunday, November 9, 2008 - 9:53am
tags:
Biotech firms fear pricing pressure from Obama
San Francisco Chronicle, CA
Sunday, November 9, 2008 - 9:39am
tags:
Santarus Prevails on Claims Disputed by Par Pharmaceutical at Markman Hearing
PR - Indside
Sunday, November 9, 2008 - 9:38am
tags:
SALVAT Announces Submission of Complete Response to FDA Approvable Letter for CETRAXAL(R)
PR - Inside
Sunday, November 9, 2008 - 9:35am
tags:
Generic drug cos await US healthcare policies
Hindu Business Line, India
Sunday, November 9, 2008 - 9:32am
tags:
Merck Reaffirms Cardiovascular Research Commitment
Genetic Engineering News
Saturday, November 8, 2008 - 1:16pm
tags:
Zevalin sales spark big jump in Cell Therapeutics Q3 sales
bizjournals.com
Saturday, November 8, 2008 - 12:51pm
tags:
Dendreon’s Q3 loss grows
bizjournals.com
Saturday, November 8, 2008 - 12:50pm
tags:
Abbott's HUMIRA® (adalimumab) Data Shows Fistula Healing For Up To Three Years In Patients With Moderate To Severe Crohn's Disease
Medical News Today
Saturday, November 8, 2008 - 12:45pm
tags:
Phase III Study (SATURN) Showed Tarceva Improved Progression-Free Survival As A First-Line Maintenance Therapy For Advanced Non-Small Cell Lung Cancer
Medical News Today
Saturday, November 8, 2008 - 12:44pm
tags:

Pages

Latest CP Wire Articles

Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility

Latest Pharmagather Articles

A Pfight at Pfizer
In the Pipeline
Clinical Trial Volunteers, And Others
In the Pipeline
The 340B Program Reached $66 Billion in 2023—Up 23% vs. 2022: Analyzing the Numbers and HRSA’s Curious Actions
Drug Channels
HCN in Acetonitrile, You Say?
In the Pipeline
Informa Connect’s Trade and Channel Strategies
Drug Channels
AI Does Not Make It Easy
In the Pipeline
The Promise of a Direct-to-Patient Model—Breaking Down What’s Really Needed for Better Patient Access
Drug Channels
Accelerated Approval: What Is It Accomplishing?
In the Pipeline
Cleaning up "Scientific Reports": Can It Be Done?
In the Pipeline

Latest Jobs

Account Manager-Orlando, FL-Ophthalmics
Maitland, Florida, 32794
Sun Pharmaceutical Industries, Inc.
Account Manager-Orlando, FL-Ophthalmics
Alafaya, Florida
Sun Pharmaceutical Industries, Inc.
Account Manager-Orlando, FL-Ophthalmics
Union Park, Florida
Sun Pharmaceutical Industries, Inc.
Account Manager-Houston West-Ophthalmics
Bunker Hill Village, Texas
Sun Pharmaceutical Industries, Inc.
Account Manager-Phoenix, AZ-Oncology
Paradise Valley, Arizona, 85253
Sun Pharmaceutical Industries, Inc.
Account Manager-Houston West-Ophthalmics
Pasadena, Texas, 77505
Sun Pharmaceutical Industries, Inc.
Account Manager-Houston West-Ophthalmics
Cloverleaf, Texas
Sun Pharmaceutical Industries, Inc.
Account Manager-Orlando, FL-Ophthalmics
Gotha, Florida, 34734
Sun Pharmaceutical Industries, Inc.
Account Manager-Orlando, FL-Ophthalmics
Longwood, Florida, 32791
Sun Pharmaceutical Industries, Inc.
Territory Manager - Medical Dermatology, Richmond VA
Richmond
Sun Pharmaceutical Industries, Inc.
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information